Evidence map›Paper›PMID 29862503›Full record

ArticleThe Journal of physiology2018

VEGF-A inhibits agonist-mediated Ca

Xi Ye, Taylor Beckett, Pooneh Bagher, Christopher J Garland, Kim A Dora

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Guidelines for evaluating endothelial function in vascular tissue.American journal of physiology. Heart and circulatory physiology · 2026
    Review
  2. Article
  3. Review
  4. The Role of the VEGF Family in Coronary Heart Disease.Frontiers in cardiovascular medicine · 2021
    Review
  5. Review
  6. Endothelial CaInternational journal of molecular sciences · 2019
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Xi YeDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK.ORCID 0000-0002-1694-2786
Taylor BeckettDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK.
Pooneh BagherDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK.
Christopher J GarlandDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK.
Kim A DoraDepartment of Pharmacology, University of Oxford, Mansfield Road, Oxford, UK.ORCID 0000-0002-8014-2775
Mansfield University · USTexas A&M Health Science Center · US

Funding

British Heart Foundation FS/13/16/30199British Heart Foundation PG/14/58/30998British Heart Foundation PG/18/11/33552British Heart Foundation RE/13/1/30181
6 · The paper itself

Abstract

key pointsProlonged exposure to vascular endothelial growth factor A (VEGF-A) inhibits agonist-mediated endothelial cell Ca ABSTRACT: Vascular endothelial growth factor A (VEGF-A) is a potent permeability and angiogenic factor that is also associated with the remodelling of the microvasculature. Elevated VEGF-A levels are linked to a significant increase in the risk of cardiovascular dysfunction, although it is unclear how VEGF-A has a detrimental, disease-related effect. Small resistance arteries are central determinants of peripheral resistance and endothelium-dependent hyperpolarization (EDH) is the predominant mechanism by which these arteries vasodilate. Using isolated, pressurized resistance arteries, we demonstrate that VEGF-A acts via VEGF receptor-2 (R2) to inhibit both endothelial cell (EC) Ca

Indexed as

VasodilationAnimalsCalciumEndothelium, VascularInositol 1,4,5-Trisphosphate ReceptorsIntermediate-Conductance Calcium-Activated Potassium ChannelsMaleMAP Kinase Kinase 1MAP Kinase Kinase 2Mesenteric ArteriesMiceMice, Inbred C57BLOligopeptidesReceptors, Vascular Endothelial Growth FactorVascular Endothelial Growth Factor AVascular ResistanceCalciumInositol 1,4,5-Trisphosphate ReceptorsIntermediate-Conductance Calcium-Activated Potassium ChannelsItpr1 protein, mouseMap2k1 protein, mouseMap2k2 protein, mouseMAP Kinase Kinase 1MAP Kinase Kinase 2OligopeptidesReceptors, Vascular Endothelial Growth Factorseryl-leucyl-isoleucyl-glycyl-arginyl-leucineVascular Endothelial Growth Factor Avascular endothelial growth factor A, mouseendothelial cell calciumendothelium-derived hyperpolarizing factorMEKvasodilationVEGF-A

Identifiers

PMID29862503
PMCPMC6092303
OpenAlexW2805787068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.